InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.34
(
0.49%
)
Bitcoin
57,870.15
(
-3.81%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Jesspro

Send PM Follow Ignore
Followers 40
Posts 6069
Boards Moderated 1
Alias Born 06/29/2011

Jesspro

Re: micanwait post# 52692

Friday, 08/15/2014 7:46:55 AM

Friday, August 15, 2014 7:46:55 AM

Post# of 80490
Mican, your statement is good for the lawyers that it could be "malpractice to make a patient go through a series of relapses before pona". knowing that there is a 100% chance of mutation in other TKIs versus the AEs in pona, the doctors should give the patients the freedom of choice in treatment. If they don't give patients the choice, they could be liable for malpractice. Others, can you weigh in on this?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up